Viridian Therapeutics, Inc.\DE (VRDN) Prepaid Assets (2013 - 2026)
Viridian Therapeutics, Inc.\DE (VRDN) posted quarterly Prepaid Assets of $22.6 million for Q1 2026, up 9.5% year-over-year from $20.6 million in Q1 2025, and up 15.23% quarter-over-quarter from $19.6 million in Q4 2025.
Analysis
Viridian Therapeutics, Inc.\DE (VRDN) Prepaid Assets (2013 - 2026) Analysis & Trends
Viridian Therapeutics, Inc.\DE's Prepaid Assets history runs 14 years deep, the most recent figure standing at $22.6 million for Q1 2026.
- In Q1 2026, Prepaid Assets rose 9.5% year-over-year to $22.6 million; the TTM figure through Mar 2026 stood at $22.6 million (up 9.5% YoY), while the FY2025 annual figure was $19.6 million, down 6.21% from the prior year.
- Prepaid Assets for Q1 2026 stood at $22.6 million, up from $19.6 million in the prior quarter.
- The five-year high for Prepaid Assets was $22.6 million in Q1 2026, with the low at $3.4 million in Q1 2022.
- The 5-year median for Prepaid Assets is $11.0 million (2025), against an average of $12.2 million.
- The sharpest annual moves came in 2023 and 2025: Prepaid Assets soared 180.83% in 2023, then fell 21.92% in 2025.
- Viridian Therapeutics, Inc.\DE's Prepaid Assets stood at $6.5 million in 2022, then soared by 38.11% to $9.0 million in 2023, then surged by 131.81% to $20.9 million in 2024, then declined by 6.21% to $19.6 million in 2025, then grew by 15.23% to $22.6 million in 2026.
- Business Quant data shows VRDN's Prepaid Assets at $22.6 million in Q1 2026, $19.6 million in Q4 2025, and $11.0 million in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Viridian Therapeutics, Inc.\DE | 2.42 Bn | 2.42 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 24.74 Mn |
| Mar 31, 2026 | 22.56 Mn |
| Dec 31, 2025 | 19.58 Mn |
| Sep 30, 2025 | 11.01 Mn |
| Jun 30, 2025 | 15.39 Mn |
| Mar 31, 2025 | 20.61 Mn |
| Dec 31, 2024 | 20.88 Mn |
| Sep 30, 2024 | 14.10 Mn |
| Jun 30, 2024 | 10.30 Mn |
| Mar 31, 2024 | 13.53 Mn |
| Dec 31, 2023 | 9.01 Mn |
| Sep 30, 2023 | 10.73 Mn |
| Jun 30, 2023 | 11.94 Mn |
| Mar 31, 2023 | 8.62 Mn |
| Dec 31, 2022 | 6.52 Mn |
| Sep 30, 2022 | 5.64 Mn |
| Jun 30, 2022 | 4.25 Mn |
| Mar 31, 2022 | 3.44 Mn |
| Dec 31, 2021 | 2.75 Mn |
| Sep 30, 2021 | 3.65 Mn |